Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-1 of 1
Keywords: Recurrent bladder cancer
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary Center
Available to PurchaseSubject Area:
Further Areas
Mulham Al-Nader, Ulrich Krafft, Christopher Darr, Jochen Heß, Claudia Kesch, Lukas Püllen, Stephan Tschirdewahn, Umut-Ulas Yesilyurt, Aykhan Isgandarov, Boris Hadaschik, Osama Mahmoud
Journal:
Urologia Internationalis
Urol Int 337–345.
Published Online: 16 December 2024
... was 14.2 months, and OS ranged from 2 to 60 months. The pooled analysis showed a better OS for patients treated with metastasectomy compared to non-surgically treated patients (HR 0.63; 95% CI; 0.49–0.81, p = 0.00) [ 28 ]. Oligometastatic Recurrent bladder cancer Metastasectomy We...
